CD4 and neoplasm: In the orthotopic mouse GL261 model, the number of CD8+ T cells in tumor tissues significantly increased after NIC treatment; the incidence of CD4+ FoxP3+ T cells was significantly decreased; tumor M1 macrophages were significantly increased; the systemic immune response was increased; serum interleukin levels were slightly elevated.